Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. Sertori"'
Autor:
Marco Motta, M. Uccelli, P. Del Poggio, G. Cesana, Stefano Olmi, Anna Fargnoli, N. Sertori, Federico Bracchi, Carlo Lombardi, Monica Taverna, D. Di Mauro, Francesca Martini, A. D’Alessio, Marcello Cottini, Cristina Giussani
Publikováno v:
Asian Journal of Medicine and Health. :15-26
Background: Hydroxychloroquine (HCQ) has been used against SARS-CoV-2, but large non randomized studies failed to show any clinical benefit. However, in these studies the drug was started in the hospital setting, a significant time after the onset of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b09abab919471203895e26e3bdb8d48
https://doi.org/10.9734/ajmah/2021/v19i230301
https://doi.org/10.9734/ajmah/2021/v19i230301
Autor:
Federico Bracchi, D. Di Mauro, A. D’Alessio, G. Borra, G. Vitale, M. Giacomini, P. Moro, Anna Fargnoli, G. Cesana, Cristina Giussani, N. Sertori, Marco Motta, P. Del Poggio
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d74719ce3af92a4677eef5372ba50e9
http://europepmc.org/articles/PMC7654848
http://europepmc.org/articles/PMC7654848
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D'Alessio A; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Del Poggio P; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy. paolo.delpoggio51@gmail.com., Bracchi F; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Cesana G; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Sertori N; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Di Mauro D; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Fargnoli A; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Motta M; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Giussani C; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Moro P; COVID Medical Department, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Vitale G; Intensive Care Unit, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Giacomini M; Intensive Care Unit, Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy., Borra G; Policlinico S.Marco Gruppo San Donato University and Research Hospital, Zingonia, Bergamo, Italy.
Publikováno v:
Leukemia [Leukemia] 2021 Feb; Vol. 35 (2), pp. 635-638. Date of Electronic Publication: 2020 Nov 10.